Is mixing and matching Covishield, Covaxin safe? Study provides BIG update
A total of 330 volunteers, who were not vaccinated and had no history of the COVID-19 infection, were selected and screened for SARS-CoV-2 antibodies for the study.
Jan 04, 2022, 07:14 AM IST
Covaxin safe for children 2-18: Bharat Biotech
Bharat Biotech had conducted studies to evaluate the safety, reactogenicity, and immunogenicity of Covaxin in healthy children and adolescents in the 2-18 age group, a press release from the vaccine maker said.
Dec 30, 2021, 18:57 PM IST
Vaccination of children: When and where to register, what are the vaccine options for those in 15-18 age group?
The vaccine option for those in the 15-18 age group would only be Covaxin, according to the "Guidelines for COVID-19 vaccination of children between 15-18 years and precaution dose to HCWs, FLWs and 60+ population with comorbidities" issued by the Union health ministry on Monday.
Dec 28, 2021, 07:30 AM IST
'Proven record for safety': Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 years
"Covaxin has established a proven record for safety and efficacy in adults for the original variant and subsequent variants. We have documented excellent safety and immunogenicity data readouts in Children," Bharat Biotech said.
Dec 26, 2021, 06:16 AM IST
Bharat Biotech seeks DCGI nod for India's 1st intranasal COVID vaccine
Bharat Biotech submitted a phase 3 clinical trial application to the Drugs Controller General of India.
Dec 20, 2021, 20:03 PM IST
Covaxin for kids aged 2-18, Centre examining Expert Committee recommendations
The Central government is examining the recommendation to grant market authorization to Covaxin for the age group of 2 to 18 years.
Nov 30, 2021, 23:55 PM IST
Covaxin 50% effective against symptomatic Covid cases: Lancet study
The Delta variant was the dominant strain in India during the study period, accounting for approximately 80 per cent of all confirmed Covid-19 cases.
Nov 25, 2021, 10:53 AM IST
Supreme Court refuses to defer Tripura civic polls
Delhi CM Arvind Kejriwal on Tuesday said that his party will improve the situation in Punjab govt schools just like they did in Delhi. The AAP chief also said that he will resolve all issues of teachers on an urgent basis if his party wins assembly polls in Punjab.
Nov 23, 2021, 08:30 AM IST
Good news! UK adds India-made Covaxin to its list of approved COVID-19 vaccines
It will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms.
Nov 23, 2021, 08:11 AM IST
Developing Covaxin in ‘just 10 months’ was an enormous challenge: Bharat Biotech
Addressing a session on Thursday at the Bengaluru Tech Summit-2021, Bharat Biotech Director, V Krishna Mohan said there were no vaccines when the Covid-19 hit India, and the world.
Nov 19, 2021, 06:22 AM IST
Covaxin found to have 77.8 per cent efficacy rate against COVID-19: Lancet
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against COVID-19. This report was published in a long-awaited analysis published in The Lancet.
Nov 12, 2021, 14:44 PM IST
Bharat Biotech's Covaxin shows 77.8 % efficacy against COVID: Lancet study
"COVAXIN is the only COVID-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the delta variant at 65.2 per cent," the official statement issued by Bharat Biotech said citing the study by the Lancet.
Nov 12, 2021, 10:21 AM IST
96 nations accept India's Covid vaccination certificates, says Union Health Minister Mansukh Mandaviya
Mandaviya also said that out of eight World Health Organisation-approved vaccines against Covid-19 in Emergency Use Listing (EUL), two vaccines - Covaxin and Covishield - are from India.
Nov 10, 2021, 09:16 AM IST
From shocking death of kids in Bhopal hospital fire to UK's Covaxin nod, here's today's news capsule
Here are some of the top news headlines of the day
Nov 09, 2021, 07:57 AM IST
Good news for Indian travellers! UK to add Covaxin to approved list from November 22
The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India. Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.
Nov 09, 2021, 06:18 AM IST
Covaxin for kids: Bharat Biotech's partner requests approval for ages 2-18 in US
Bharat Biotech's US partner Ocugen has approached US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18
Nov 06, 2021, 11:23 AM IST
WHO's approval to Covaxin will facilitate foreign travel for Indians: EAM S Jaishankar
The World Health Organisation (WHO) had on Wednesday granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
Nov 04, 2021, 07:51 AM IST
A shot in the arm for India! Bharat Biotech's Covaxin gets WHO approval for emergency use
The Technical Advisory Group (TAG)-Emergency use listing (EUL) is an independent advisory group that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.
Nov 03, 2021, 17:26 PM IST
Emergency use nod to Bharat Biotech's Covaxin: WHO's Technical Advisory Group to decide today
The technical panel had earlier sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of the vaccine.
Nov 03, 2021, 06:45 AM IST
COVID-19: Good news for Indians as Australia recognises Covaxin
Australia's Therapeutic Goods Administration said that this will have significant impacts on the return of international students, and the travel of skilled and unskilled workers to Australia.
Nov 01, 2021, 12:12 PM IST
